D. Aubert

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Richard J Stephens, Lesley Seymour, Valter Torri, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation

J. Pignon, R. Stephens, L. Seymour, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

H. Sommer, M. Untch, P. Kellokumpu-Lehtinen, 2006, British Journal of Cancer.

Pr3 ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I–III) non small cell lung cancer (NSCLC) patients (pts)

R. Ramlau, R. Rosell, J. Douillard, 2005 .

Oral Vinorelbine and Cisplatin with Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

R. Fietkau, R. Huber, M. Flentje, 2006, Oncology Research and Treatment.

801 Oral chemotherapy and upper gastro-intestinal tolerance (UGT) improvement of nausea and vomiting in non-small-cell-lung-cancer (NSCLC) patients (pts) treated with oral navelbine (NVB) and standard antiemetic prophylaxis

C. Gridelli, J. Jassem, D. Aubert, 2003 .

Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer.

R. Ramlau, J. Jassem, P. Kosmidis, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial.

R. Stahel, F. de Marinis, D. Betticher, 2004, European journal of cancer.

GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients.

R. V. van Klaveren, U. Gatzemeier, A. Price, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Single agent oral vinorelbine (NVB) in advanced non-small cell lung cancer (NSCLC) in the elderly: Patient benefit improvement by weekly schedule

C. Gridelli, J. Pouget, C. Manegold, 2004 .

P-544 Final results of a phase I study with navelbine (NVB) oral in combination with cisplatin (C), evaluating two different schedules in advanced non-small cell lung cancer (NSCLC) patients

Yuh-Min Chen, R. Perng, Pan‐Chyr Yang, 2003 .

Cisplatin-Based Three Drugs Combination (NIP) as Induction and Adjuvant Treatment in Locally Advanced Non-small Cell Lung Cancer: Final Results

R. Perng, R. Ramlau, M. Krzakowski, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.